News Image

Oncolytics Biotech® Presents Aggregated Translational Data Providing Evidence of Pelareorep's Effectiveness Across Multiple Tumor Types

Provided By PR Newswire

Last update: Jul 16, 2025

Integrated biomarker analyses confirm viral replication, interferon signaling, and a surge in tumor-infiltrating lymphocytes after pelareorep treatment

Read more at prnewswire.com

ONCOLYTICS BIOTECH INC

NASDAQ:ONCY (8/8/2025, 8:00:02 PM)

After market: 0.84 -0.02 (-2.14%)

0.8584

-0.06 (-6.2%)



Find more stocks in the Stock Screener

Follow ChartMill for more